178 related articles for article (PubMed ID: 38167440)
1. TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis.
Hao XL; Lv YF; Li DF; Bai FH; Gong J; Pan GQ; Su LX; Wang YL; Fu WL; Liu B; Huang L; Yan D; Tan QL; Liu JY; Guo QN
J Transl Med; 2024 Jan; 22(1):6. PubMed ID: 38167440
[TBL] [Abstract][Full Text] [Related]
2. Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.
Hao XL; Gao LY; Deng XJ; Han F; Chen HQ; Jiang X; Liu WB; Wang DD; Chen JP; Cui ZH; Ao L; Cao J; Liu JY
Cell Death Dis; 2019 May; 10(6):424. PubMed ID: 31142739
[TBL] [Abstract][Full Text] [Related]
3. PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
J Exp Clin Cancer Res; 2019 Jun; 38(1):256. PubMed ID: 31196157
[TBL] [Abstract][Full Text] [Related]
4. Neddylation of PTEN regulates its nuclear import and promotes tumor development.
Xie P; Peng Z; Chen Y; Li H; Du M; Tan Y; Zhang X; Lu Z; Cui CP; Liu CH; He F; Zhang L
Cell Res; 2021 Mar; 31(3):291-311. PubMed ID: 33299139
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway.
Zhang XY; Mao L
Gene; 2021 Jan; 766():145113. PubMed ID: 32891771
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
9. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin Inhibits Breast Cancer Cells by Downregulating PTEN/AKT Pathway via Promoting Ras Homolog Family Member B (RhoB).
Ma Q; Gao Y; Xu P; Li K; Xu X; Gao J; Qi Y; Xu J; Yang Y; Song W; He X; Liu S; Yuan X; Yin W; He Y; Pan W; Wei L; Zhang J
Biomed Res Int; 2019; 2019():3235021. PubMed ID: 31011573
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.
Miao Y; Zheng W; Li N; Su Z; Zhao L; Zhou H; Jia L
Sci Rep; 2017 Feb; 7():41942. PubMed ID: 28165066
[TBL] [Abstract][Full Text] [Related]
12. Odontogenic ameloblast-associated protein (ODAM) inhibits growth and migration of human melanoma cells and elicits PTEN elevation and inactivation of PI3K/AKT signaling.
Foster JS; Fish LM; Phipps JE; Bruker CT; Lewis JM; Bell JL; Solomon A; Kestler DP
BMC Cancer; 2013 May; 13():227. PubMed ID: 23648148
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway.
Xu T; Rao T; Yu WM; Ning JZ; Yu X; Zhu SM; Yang K; Bai T; Cheng F
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907827
[TBL] [Abstract][Full Text] [Related]
14. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
15. The tRNA-derived fragment 5026a inhibits the proliferation of gastric cancer cells by regulating the PTEN/PI3K/AKT signaling pathway.
Zhu L; Li Z; Yu X; Ruan Y; Shen Y; Shao Y; Zhang X; Ye G; Guo J
Stem Cell Res Ther; 2021 Jul; 12(1):418. PubMed ID: 34294122
[TBL] [Abstract][Full Text] [Related]
16. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
18. MiR-202-5p/
Liu T; Guo J; Zhang X
Cancer Biol Ther; 2019; 20(7):989-998. PubMed ID: 30983514
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling.
Liu C; Liu Z; Li X; Tang X; He J; Lu S
Oncol Rep; 2017 Oct; 38(4):2435-2443. PubMed ID: 28791363
[TBL] [Abstract][Full Text] [Related]
20. PdpaMn inhibits fatty acid synthase-mediated glycolysis by down-regulating PI3K/Akt signaling pathway in breast cancer.
Okrah EA; Wang Q; Fu H; Chen Q; Gao J
Anticancer Drugs; 2020 Nov; 31(10):1046-1056. PubMed ID: 32649369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
